AJP - GI Add DOIs to your references at manuscript stage!
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Gastrointest Liver Physiol (May 8, 2008). doi:10.1152/ajpgi.00024.2008
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
295/1/G45    most recent
00024.2008v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hu, B.
Right arrow Articles by Colletti, L. M
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hu, B.
Right arrow Articles by Colletti, L. M
Submitted on January 17, 2008
Accepted on May 4, 2008

Stem cell factor and c-kit are involved in hepatic recovery after acetaminophen-induced liver injury in mice

Bin Hu1 and Lisa M Colletti1*

1 Surgery, University of Michigan Medical School, Ann Arbor, Michigan, United States

* To whom correspondence should be addressed. E-mail: colletti{at}med.umich.edu.

Stem cell factor (SCF) and its receptor c-kit are important in hematopoiesis and cellular proliferation. C-kit has also been identified as a cell surface marker for progenitor cells. We have previously shown that there is a large reservoir of hepatic SCF and this molecule plays a significant role in liver regeneration after 70% hepatectomy. In the current study, we further examined the expression of SCF and c-kit in acetaminophen (APAP)-induced liver injury in C57BL/6J mice or SCF-deficient sl-sld mice and their appropriate wild type controls. Following APAP-induced liver injury, c-kit mRNA expression increased, with peak levels detected 48 hours post-injury. Hepatic SCF mRNA levels after APAP injury were also increased, with peak levels seen 16 hours post-APAP. The mortality rate in SCF-deficient mice treated with APAP was significantly higher than that of wild type mice; further, administration of exogenous SCF significantly reduced the mortality of APAP-treated wild-type mice. BrdU incorporation experiments showed that SCF significantly increased hepatocyte proliferation at 48 and 72 hours in APAP-treated mice. SCF inhibited APAP-induced hepatocyte apoptosis and increased Bcl-2 and Bcl-xL expression, suggesting this decrease in hepatocyte apoptosis is mediated through Bcl-2 and Bcl-xL. In summary, SCF and c-kit expression were increased after APAP-induced liver injury. Administration of exogenous SCF reduces mortality in APAP-treated mice, increases hepatocyte proliferation and prevents hepatocyte apoptosis induced by APAP, suggesting that these molecules are important in the liver's recovery from these injuries.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 1977 by the American Physiological Society.